Literature DB >> 14163106

MONOAMINE OXIDASE INHIBITORS, TYRAMINE, AND CHESSE.

D HORWITZ, W LOVENBERG, K ENGELMAN, A SJOERDSMA.   

Abstract

Entities:  

Keywords:  CHEESE; FOOD ANALYSIS; HYPERTENSION; IMIPRAMINE; MEPERIDINE; MONOAMINE OXIDASE INHIBITORS; NIALAMIDE; PHARMACOLOGY; PHENELZINE; PHENTOLAMINE; TOXICOLOGIC REPORT; TRANYLCYPROMINE; TYRAMINE

Mesh：

Substances：

Year:  1964        PMID： 14163106     DOI： 10.1001/jama.1964.03060390010002

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  29 in total

1.  Migraine.

Authors:  N H Raskin
Journal:  West J Med       Date:  1975-09

2.  HYPERTENSIVE CRISIS DUE TO PARGYLINE AND METARAMINOL.

Authors:  A R HORLER; N A WYNNE
Journal:  Br Med J       Date:  1965-08-21

3.  [Interactions between nutrition and drugs].

Authors:  G Czok
Journal:  Z Ernahrungswiss       Date:  1976-06

4.  Combining Stimulants and Monoamine Oxidase Inhibitors: A Reexamination of the Literature and a Report of a New Treatment Combination.

Authors:  Joshua A Israel
Journal:  Prim Care Companion CNS Disord       Date:  2015-12-10

5.  Moclobemide, a new reversible MAO inhibitor--interaction with tyramine and tricyclic antidepressants in healthy volunteers and depressive patients.

Authors:  A Korn; H G Eichler; R Fischbach; S Gasic
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

6.  M.A.O. inhibitors and headache.

Authors:  A J Cooper
Journal:  Br Med J       Date:  1967-11-18

7.  The mechanism of the augmentation of responses to indirectly acting sympathomimetic amines by monoamine oxidase inhibitors.

Authors:  M J Rand; F R Trinker
Journal:  Br J Pharmacol Chemother       Date:  1968-06

8.  [Report on a intracerebral hemorrhage after long term treatment with a monoamine oxidase inhibitor (MAO)].

Authors:  F Römer; W J Bock
Journal:  Acta Neurochir (Wien)       Date:  1970-04-21       Impact factor: 2.216

Review 9.  The molecular basis of familial dysautonomia: overview, new discoveries and implications for directed therapies.

Authors:  Berish Y Rubin; Sylvia L Anderson
Journal:  Neuromolecular Med       Date:  2007-11-06       Impact factor: 3.843

10.  Comparison of Monoamine Oxidase Inhibitors in Decreasing Production of the Autotoxic Dopamine Metabolite 3,4-Dihydroxyphenylacetaldehyde in PC12 Cells.

Authors:  David S Goldstein; Yunden Jinsmaa; Patti Sullivan; Courtney Holmes; Irwin J Kopin; Yehonatan Sharabi
Journal:  J Pharmacol Exp Ther       Date:  2015-11-16       Impact factor: 4.030
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.